# A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)

> **NCT01469715** · PHASE2 · COMPLETED · sponsor: **University of Virginia** · enrollment: 16 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** GBP CGM

## Key facts

- **NCT ID:** NCT01469715
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-07-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01469715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01469715, "A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01469715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*